Liraglutide Market to Witness Robust Expansion by 2023

New report published by Market Research Report Store (MRRS) which offers insights on the global Liraglutide market.

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/722/global-liraglutide-market-growth

Global Liraglutide Market: Forecast by Type / Application / Region

The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.

The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

Over the next five years, LPI(LP Information) projects that Liraglutide will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

Global Liraglutide Market: Key Players
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.marketresearchreportstore.com/reports/722/global-liraglutide-market-growth

Related Information:
United States Liraglutide Market Research Report 2018
Europe Liraglutide Market Research Report 2018
North America Liraglutide Market Research Report 2018
Asia-Pacific Liraglutide Market Research Report 2018
China Liraglutide Market Research Report 2018
EMEA Liraglutide Market Research Report 2018
Global Liraglutide Market Research Report 2018

About Us:
Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. Owing to our good service and the professional market reports in the wide range, MRRS enjoys a good reputation in the market. In pace with the development of MRRS, more and more customers and market report publishers choose to cooperate with us. As a specialized platform, MRRS upholds the supremacy of customers and aims to provide customers with better service and richer select.

Contact US :
Sales Director (Market Research Report Store)
E-mail: info@marketresearchreportstore.com
Tel: +86-15521064060 00852-58197708(HK)
Add: 17890 Castleton Street Suite 218 City of Industry CA 91748 United States
Website: https://www.marketresearchreportstore.com

This release was published on openPR.